Fairvalue-Calculator Fairvalue-Calculator
EN DE

Pulmuone Corporate (017810) Fair Value & Analysis

Consumer Defensive · KR · Market cap 363B KRW

Price9,140 KRW
Fair Value14,562 KRW
Upside+59.3%
Quality80/100
Evidence: Medium Range 7,725 KRW – 24,411 KRW

Fair value as of: Jun 24, 2026

Analysis

Pulmuone Corporate (017810) currently trades at 9,140 KRW, while our model-based Fair Value estimate is 14,562 KRW — implying the stock looks roughly 59.3% undervalued today. We read business quality at 80/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Pulmuone Corporate manufactures, sells, and distributes foods and beverages in South Korea, the United States, China, and Japan. The company provides functional foods, mineral water, and fermented milk products, as well as meal, concession, and catering services; and distributes whole foods. It also offers health and living solutions. Pulmuone Corporate was founded in 1981 and is headquartered in Eumseong-eup, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Pulmuone Corporate (017810) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 14,562 KRW versus a price of 9,140 KRW — about +59% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 017810?
Our 21-model fair value for Pulmuone Corporate is 14,562 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 9,140 KRW.
What is the quality score of 017810?
Pulmuone Corporate has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.